Douglas Janzen
Chief Executive Officer at AEQUUS PHARMACEUTICALS INC.
Net worth: 138 092 $ as of 2024-03-30
Profile
Douglas Glen Janzen is the founder and currently holds the position of Chairman, President & Chief Executive Officer at Aequus Pharmaceuticals, Inc., which was founded in 2013.
He is also the founder and currently serves as President, Chief Executive Officer & MD at Northview Ventures, Inc., founded in 2012.
Additionally, he is the founder and currently holds the position of Managing Director at Northview Ventures & Associates General Partnership, founded in 2014.
Mr. Janzen's current job(s) include being the Chairman at Lexington Biosciences Holdings Corp., starting in 2017.
He is also the Director & Managing Director at LifeSciences British Columbia since 2010, an Independent Director at Neovasc, Inc. since 2005, and a Director at Perimeter Medical Imaging, Inc., Synaptive Technologies Ltd., Transdermal Research Pharm Laboratories LLC, and Alabaster Technologies, Inc. In his former positions, Mr. Janzen served as the President, Chief Executive Officer & Director at Correvio Pharma Corp.
from 2003 to 2012.
He was also the Chairman at AbCellera Biologics, Inc. and Lexington Biosciences, Inc. from 2016 to 2021.
Furthermore, he held various director positions at Medical Ventures Corp., Teal Valley Health, Inc., Aptamera, Inc., Synaptive Medical, Inc., BIOTECanada, iCo Therapeutics, Inc., Sentinelle Medical ULC, BioHEP Technologies Ltd., Renaissance BioScience Corp., AmpHP, Inc., and Perimeter Medical Imaging AI, Inc. He also worked as an Analyst at Cormark Securities, Inc. in 2002 and served as the President & Chief Business Officer at Bradmer Pharmaceuticals, Inc. from 2006 to 2007.
Prior to that, he was the Head of Research at Loewen, Ondaatje, McCutcheon Ltd.
from 1998 to 2001.
Mr. Janzen's education includes a graduate degree from the University of British Columbia and an undergraduate degree from the University of Saskatchewan.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-06-19 | 12,553,800 ( 9.46% ) | 138 092 $ | 2024-03-30 |
Douglas Janzen active positions
Companies | Position | Start |
---|---|---|
NEOVASC INC. | Director/Board Member | 2005-06-01 |
AEQUUS PHARMACEUTICALS INC. | Chief Executive Officer | 2013-01-02 |
Alabaster Technologies, Inc. | Director/Board Member | - |
Lexington Biosciences Holdings Corp.
Lexington Biosciences Holdings Corp. Medical SpecialtiesHealth Technology Lexington Biosciences Holdings Corp. engages in the development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The company was founded by Bradley Hoeppner on April 12, 2016 and is headquartered in Vancouver, Canada. | Chairman | 2017-05-22 |
Northview Ventures & Associates General Partnership
Northview Ventures & Associates General Partnership Miscellaneous Commercial ServicesCommercial Services Northview Ventures & Associates General Partnership is a business management consultant. The company was founded by Doug G. Janzen and is headquartered in Vancouver, Canada. | Chief Executive Officer | 2014-03-31 |
Transdermal Research Pharm Laboratories LLC | Director/Board Member | 2013-03-02 |
Synaptive Technologies Ltd. | Director/Board Member | - |
Northview Ventures, Inc. | Chief Executive Officer | 2012-10-31 |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Director/Board Member | - |
Former positions of Douglas Janzen
Companies | Position | End |
---|---|---|
░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Douglas Janzen
University of British Columbia | Graduate Degree |
University of Saskatchewan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
AEQUUS PHARMACEUTICALS INC. | Health Technology |
ABCELLERA BIOLOGICS INC. | Health Technology |
REGISTERED PLAN PRIVATE INVESTMENTS INC. | Health Technology |
PERIMETER MEDICAL IMAGING AI, INC. | Health Technology |
Private companies | 23 |
---|---|
Cormark Securities, Inc.
Cormark Securities, Inc. Investment Banks/BrokersFinance Cormark Securities Inc. (Cormark) is an independent investment dealer headquartered in Toronto, Canada with additional office in Calgary. The firm was founded in 1981 as Sprott Securities, Inc. Cormark Securities provides execution and comprehensive coverage of Canadian listed companies to domestic and international institutional investors. They focus on Canadian-listed, mid-cap and emerging growth companies. | Finance |
Correvio Pharma Corp.
Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Medical Ventures Corp.
Medical Ventures Corp. Electronic Equipment/InstrumentsElectronic Technology Medical Ventures Corp. develops, manufactures and distributes medical devices and is focused on the development and commercialization of medical devices which clearly address a clinical need in the cardiovascular marketplace. The Company has two divisions: PMD tissue products used in cardiac reconstruction and repair and Angiometrx catheter products for the rapidly growing interventional cardiology market. The focus in both divisions is the commercialization of the cardiovascular medical devices currently in the MEV’s product portfolio and the development of new products based upon these two core technologies. The company is located in Richmond, Canada. | Electronic Technology |
Teal Valley Health, Inc.
Teal Valley Health, Inc. Miscellaneous Commercial ServicesCommercial Services Teal Valley Health, Inc. operates as a cannabis company. It engages in the identification, evaluation, and acquisition of interests in healthcare assets and businesses, with a focus on the Canadian medical cannabis sector. The company was founded on August 30, 1994 and is headquartered in Vancouver, Canada. | Commercial Services |
Aptamera, Inc.
Aptamera, Inc. BiotechnologyHealth Technology Aptamera, Inc. develops drugs designed to attack cancer. The company is based in Louisville, KY. Aptamera was acquired by Sarossa Capital Ltd. on March 19, 2005 for $21.40 million. The company was founded by Donald Miller, John O. Trent, Paula J. Bates, Tyree G. Wilburn. | Health Technology |
Bradmer Pharmaceuticals, Inc.
Bradmer Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada. | Commercial Services |
Synaptive Medical, Inc.
Synaptive Medical, Inc. Medical SpecialtiesHealth Technology Synaptive Medical, Inc. develops medical equipment and applications for neurosurgery. Its products include birghtmatter plan, guide, drive, vision and imagedrive. The firm?s solutions offer state-of-the-art technologies, including advanced surgical planning, navigation and visualization. The company was founded by Cameron Piron in 2012 and is headquartered in Toronto, Canada. | Health Technology |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Loewen, Ondaatje, McCutcheon Ltd.
Loewen, Ondaatje, McCutcheon Ltd. Investment Banks/BrokersFinance Loewen, Ondaatje, McCutcheon Ltd. (LOM) is an independent Canadian broker/dealer firm headquartered in Toronto, Ontario. Founded in 1970, the firm combines objective research and value-added financing ideas with institutional sales, trading and investment banking. They are a provider of value-added North American research. LOM focuses exclusively on advising small and mid-cap companies, with a strong focus on select emerging growth companies in industries that include Technology, Healthcare, and Mining. | Finance |
iCo Therapeutics, Inc.
iCo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology iCo Therapeutics, Inc. is a canadian biotechnology company. It engages in the business of identification, development and commercialization of drug candidates to treat ocular and infectious diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J. Rae, John G. Clement and William John Meekison on February 15, 2005 and is headquartered in Vancouver, CA. | Health Technology |
Neovasc, Inc.
Neovasc, Inc. Medical SpecialtiesHealth Technology Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. | Health Technology |
Sentinelle Medical ULC
Sentinelle Medical ULC Packaged SoftwareTechnology Services Sentinelle technology is developed by clinicians for clinicians and has evolved over ten years and more than 10000 patient trials. Its products come out of diagnostic imaging research initially conducted at Sunnybrook Health Sciences Centre and the University of Toronto Medical Biophysics department, and continuing over the past three years at Sentinelle. Its ongoing collaboration with academic institutions ensures Sentinelle technology is at the leading edge of the field of breast MRI imaging advances. Sentinelle develops products for General Electric Healthcare, Siemens Medical Solutions and Toshiba Medical Systems. Sentinelle Medical Inc., established in 2004, is a private company based in Toronto, Canada. | Technology Services |
Northview Ventures, Inc. | |
BioHEP Technologies Ltd.
BioHEP Technologies Ltd. BiotechnologyHealth Technology Part of Next Hydrogen Solutions, Inc., BioHEP Technologies Ltd. develops biotechnologies for treatment of viral diseases. The private company is based in Vancouver, Canada. The CEO of the Canadian company is Bruce A. Schmidt. | Health Technology |
Perimeter Medical Imaging, Inc.
Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Health Technology |
Renaissance BioScience Corp.
Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Renaissance BioScience Corp. is a bioengineering private company based in Vancouver, Canada. The Canadian company specializes in microbial bioengineering innovation and develop market-ready, functional microorganisms for various industries such as agriculture, food and beverage, health, and energy. Renaissance BioScience's proprietary strain collections, breeding knowledge, fermentation, and screening platforms are used to engineer and deliver unique, scalable solutions for industry and academia. The company's technologies have created products that impact millions of people worldwide, including acrylamide-reducing yeast for safer foods and H2S-preventing wine yeast. More information about the Renaissance group of companies is available on their website. The company was founded by John Husnik and Maurice Boucher, and John Husnik has been the CEO since incorporation. | Commercial Services |
Synaptive Technologies Ltd. | |
Lexington Biosciences Holdings Corp.
Lexington Biosciences Holdings Corp. Medical SpecialtiesHealth Technology Lexington Biosciences Holdings Corp. engages in the development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The company was founded by Bradley Hoeppner on April 12, 2016 and is headquartered in Vancouver, Canada. | Health Technology |
Alabaster Technologies, Inc. | |
AmpHP, Inc.
AmpHP, Inc. Pharmaceuticals: MajorHealth Technology Amphp, Inc. provides performance and recovery lotion. It offers PR Lotion product that gives the body more bicarb (a natural electrolyte) to help muscles perform. The company was founded by Jeff Byers and Erica Good and is headquartered in Park City, UT. | Health Technology |
Transdermal Research Pharm Laboratories LLC | |
Northview Ventures & Associates General Partnership
Northview Ventures & Associates General Partnership Miscellaneous Commercial ServicesCommercial Services Northview Ventures & Associates General Partnership is a business management consultant. The company was founded by Doug G. Janzen and is headquartered in Vancouver, Canada. | Commercial Services |
- Stock Market
- Insiders
- Douglas Janzen